Resistance to the top malaria drug has fanned out from its origins in Cambodia to other parts of Southeast Asia. A report in the July 31 New England Journal of Medicine establishes that the scourge has found a way to skirt the effects of artemisinin and its chemical derivatives, the best available antimalarial drugs.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.